SIC
XBIT icon

Salem Investment Counselors’s XBiotech XBIT Stock Holding History

Salem Investment Counselors’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-500
Closed -$2K – 533
2018
Q2 		$2K Buy
+500
New +$2.26K ﹤0.01% 505
2018
Q1 		– Sell
-500
Closed -$2K – 572
2017
Q4 		$2K Buy
+500
New +$2.1K ﹤0.01% 527

Other funds holding XBIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
ECM
Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Salem Investment Counselors's XBIT Position: Q3 2018 in Review

Salem Investment Counselors sold out of XBiotech (XBIT) in Q3 2018, closing a stake of 500 shares — an estimated $2K sold.

Salem Investment Counselors first reported a position in XBIT in Q4 2017 and held it in 2 quarters. The position peaked at $2K in Q2 2018. 24 funds tracked by Wall St. Rank hold XBIT as of Q3 2018.

  • Salem Investment Counselors reported no remaining XBiotech position as of Q3 2018 after selling out during the quarter.
  • Salem Investment Counselors sold 500 XBiotech shares in Q3 2018, an estimated $2K.
  • Salem Investment Counselors first reported a position in XBiotech in Q4 2017 and held it in 2 quarters.
  • Salem Investment Counselors's XBiotech position peaked at $2K in Q2 2018.
  • 24 funds tracked by Wall St. Rank held XBiotech as of Q3 2018.

Based on Salem Investment Counselors's 13F filing for Q3 2018, filed 14 Nov 2018.